Perspective Therapeutics, Inc. (CATX)
3.87
-0.06
(-1.53%)
USD |
NYAM |
Apr 30, 12:56
Perspective Therapeutics EPS Diluted (Quarterly) : -0.5043 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.6165 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1428 |
| Boston Scientific Corp. | 0.897 |
| Plus Therapeutics, Inc. | -1.03 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.49M |
| Revenue (Quarterly) | 0.043M |
| Total Expenses (Quarterly) | 37.53M |
| Enterprise Value | 306.27M |
| Gross Profit Margin (Quarterly) | -2.25K% |
| Profit Margin (Quarterly) | -87.19K% |
| Earnings Yield | -36.03% |
| Normalized Earnings Yield | -33.60 |